BUB
ANIK icon

BBVA USA Bancshares’s Anika Therapeutics ANIK Stock Holding History

BBVA USA Bancshares’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$669K Sell
16,411
-2,344
-12% -$88.9K 0.03% 356
2020
Q4 		$850K Sell
18,755
-498
-3% -$18.9K 0.04% 310
2020
Q3 		$689K Buy
19,253
+792
+4% +$28.6K 0.04% 316
2020
Q2 		$697K Buy
18,461
+654
+4% +$21.5K 0.04% 309
2020
Q1 		$515K Buy
17,807
+437
+3% +$17.7K 0.04% 314
2019
Q4 		$900K Sell
17,370
-1,525
-8% -$88.6K 0.05% 281
2019
Q3 		$1.04M Buy
18,895
+3,945
+26% +$203K 0.07% 224
2019
Q2 		$607K Buy
14,950
+2,213
+17% +$80.7K 0.04% 338
2019
Q1 		$385K Buy
12,737
+3,137
+33% +$107K 0.02% 406
2018
Q4 		$323K Sell
9,600
-6,089
-39% -$220K 0.02% 404
2018
Q3 		$662K Buy
15,689
+47
+0.3% +$1.86K 0.04% 338
2018
Q2 		$500K Sell
15,642
-6,138
-28% -$253K 0.03% 368
2018
Q1 		$1.08M Buy
21,780
+1,072
+5% +$60.6K 0.07% 246
2017
Q4 		$1.12M Buy
20,708
+2,451
+13% +$136K 0.07% 242
2017
Q3 		$1.06M Buy
18,257
+3,227
+21% +$169K 0.07% 253
2017
Q2 		$741K Buy
15,030
+6,852
+84% +$316K 0.05% 310
2017
Q1 		$355K Buy
+8,178
New +$390K 0.02% 422

Other funds holding ANIK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

BBVA USA Bancshares's ANIK Position: Q1 2021 in Review

BBVA USA Bancshares reduced its Anika Therapeutics (ANIK) stake by 12% in Q1 2021, selling an estimated $88.9K and leaving 16,411 shares worth $669K. The position accounts for 0.03% of the portfolio, ranked #356.

BBVA USA Bancshares first reported a position in ANIK in Q1 2017 and has held it in 17 quarters since. The position peaked at $1.12M in Q4 2017. 146 funds tracked by Wall St. Rank hold ANIK as of Q1 2021.

  • BBVA USA Bancshares held 16,411 shares of Anika Therapeutics worth $669K as of Q1 2021.
  • BBVA USA Bancshares sold 2,344 Anika Therapeutics shares in Q1 2021, an estimated $88.9K.
  • Anika Therapeutics made up 0.03% of BBVA USA Bancshares's portfolio in Q1 2021, its #356 holding.
  • BBVA USA Bancshares first reported a position in Anika Therapeutics in Q1 2017 and has held it in 17 quarters since.
  • BBVA USA Bancshares's Anika Therapeutics position peaked at $1.12M in Q4 2017.
  • 146 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2021.

Based on BBVA USA Bancshares's 13F filing for Q1 2021, filed 23 Apr 2021.